Collegium Pharmaceutical, Inc
COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31
Reports and events: 192 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1916:05 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-26-116876 |
| 2026-08-1307:30 ET | 8-K | 8.01 Other events | 0001104659-26-095464 |
| 2026-08-0607:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053851 |
| 2026-08-0607:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-26-053849 |
| 2026-06-3016:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-26-079323 |
| 2026-05-1516:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-062536 |
| 2026-05-1207:43 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-059018 |
| 2026-05-0707:34 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031697 |
| 2026-05-0707:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031694 |
| 2026-04-0716:02 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001628280-26-024063 |
| 2026-04-0716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-024061 |
| 2026-03-1917:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-032166 |
| 2026-02-2607:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011992 |
| 2026-02-2607:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011990 |
| 2026-01-0808:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001953 |
| 2025-12-3008:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-125026 |
| 2025-11-0607:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107391 |
| 2025-11-0607:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-107389 |
| 2025-08-0707:35 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010649 |
| 2025-08-0707:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010647 |
| 2025-07-0708:05 ET | 8-K | 8.01 Other events | 0001104659-25-065981 |
| 2025-05-1916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-050435 |
| 2025-05-1208:10 ET | 8-K | 8.01 Other events | 0001104659-25-047040 |
| 2025-05-0816:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006960 |
| 2025-05-0816:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006957 |
| 2025-03-2816:01 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001558370-25-003983 |
| 2025-03-1707:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-024185 |
| 2025-02-2716:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001801 |
| 2025-02-2716:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001799 |
| 2025-02-0508:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-009384 |
| 2025-01-0808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-001873 |
| 2024-11-1416:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-24-118858 |
| 2024-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014858 |
| 2024-11-0716:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115287 |
| 2024-09-0408:03 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096647 |
| 2024-08-0816:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011586 |
| 2024-08-0816:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-011583 |
| 2024-07-2906:02 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-083126 |
| 2024-06-1308:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-071070 |
| 2024-05-2416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-065119 |
| 2024-05-2016:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-063396 |
| 2024-05-1308:05 ET | 8-K | 8.01 Other events | 0001104659-24-060235 |
| 2024-05-1008:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-059656 |
| 2024-05-0916:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007601 |
| 2024-05-0916:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-007596 |
| 2024-04-2908:05 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-24-053506 |
| 2024-04-1108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046091 |
| 2024-04-0516:01 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0001558370-24-004778 |
| 2024-02-2216:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001526 |
| 2024-02-2216:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001524 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:26 ET. Listed shows no prices and gives no investment advice.